LIVE STREAM CME - Primary Care Update: Cardiology, Endocrinology and Gastroenterology is organized by MCE Conferences, Inc. and will be held from Nov 20 - 21, 2020.
Accreditation:
Accreditation Council for Continuing Medical Education – ACCME:
MCE Conferences designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
ABIM MOC Recognition:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 (part II) MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Pharmacology Credits:
This course is being reviewed and will be acceptable for up to 12 CE credits; please verify with your Medical Board which hours may be applied toward Pharmacology credit.
Overview:
This live streaming course is designed to provide primary care clinicians with up-to-date, evidence-based information on commonly encountered issues in Cardiology, Endocrinology, and Gastroenterologywhile suggesting pragmatic approaches to clinical management. The online learning format will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Cardiology, Endocrinology, and Gastroenterology for Primary Care, with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.
Schedule, Topics, and Learning Objectives
Friday, November 20th
10:00 AM – 11:00 AM (ET) / 7:00 AM – 8:00 AM (PT):
Aortic Stenosis: An Old Disease with New Treatment Options– Dr. Eli Gelfand
Objectives: 1) Understand the basic pathophysiology of AS 2) Understand the newer concepts in the timing of valve replacement, the role of stress testing, and biomarkers 3) Transcatheter aortic valve intervention: How is it done, how does it compare with surgical AVR, and whom to refer
11:00 AM – 11:05 AM (ET) / 8:00 AM – 8:05 AM (PT) ~ BREAK
11:05 AM – 12:05 PM (ET) / 8:05 AM – 9:05 AM (PT):
Mitral Regurgitation– Dr. Eli Gelfand
Objectives: 1) Understand the basic pathophysiology of MR 2) Timing of mitral valve surgical intervention: when to treat an asymptomatic patient with severe MR? 3)Emerging catheter-based therapies for MR
12:05 PM – 12:15 PM / 9:05 AM – 9:15 AM (PT) ~ BREAK
12:15 PM – 1:15 PM (ET) / 9:15 AM – 10:15 AM (PT):
Obesity: Introduction, Etiologies, Lifestyle Modifications– Dr. Damon Tanton
1) Definition of obesity 2) Measurement modalities 3) Scope of the problem 4) Association with illness 5) Global impact 6) Obesogenic Environment 7) Fat-promoting foods 8) The problem of exercise inequity 9) Fat-promoting medications 10) Endocrinologic causes [with focus on Insulin Resistance] 11) Psycho-Social influences 12) Fat-fighting foods 13) Discussion of diets [with focus on Volumetrics and Low Glycemic Load Diet] 14) The importance of protein and fiber 15) Avoidance of starvation 16) Grazing vs. Gorging 17) Optimal exercise 18) Stress reduction 19) Spiritual awareness
1:15 PM – 1:20 PM / 10:15 AM – 10:20 AM (PT) ~ BREAK
1:20 PM – 2:20 PM (ET) / 10:20 AM – 11:20 AM (PT):
Obesity: Pharmacological and Surgical Treatments – Dr. Damon Tanton
1) FDA-approved medications 2) Other commonly used treatments [will discuss off-label use] 3) Potential side effects 4) Precautions for use 5) Expected results of medications 6) Criteria for Bariatric Surgery 7) Surgical options [with emphasis on Gastric Sleeve, Laparoscopic Banding, and Roux-En-Y] 8) Potential complications of surgeries 9) Anticipated outcomes 10) Metabolic surgery
Saturday, November 21st
10:00 AM – 10:30 AM (ET) / 7:00 AM – 7:30 AM (PT):
Case Base Studies – Obesity (30 minutes) – Dr. Damon Tanton
Objectives: 1) Appropriate hormonal workup for weight pain 2) Algorithm for medicinal treatment of excessive fat 3) Escalation to various bariatric procedures
10:30 AM – 11:00 AM (ET) / 7:30 AM – 8:00 AM (PT):
Case Base Studies – Diabetes Management (30 minutes)- Dr. Damon Tanton
Objectives: 1) Use of oral agents 2) Addiction of non-insulin injectables 3) Escalation of care with multiple daily shots of insulin 4) Introduction of diabetes devices
?11:00 AM – 11:05 AM (ET) / 8:00 AM – 8:05 AM (PT) ~ BREAK
11:05 AM – 12:05 PM (ET) / 8:05 AM – 9:05 AM (PT):
Diabetes 1 and 2 – Dr. Damon Tanton
Objectives: 1) Incidence, screening, classification, genetics, diagnosis, and complications of diabetes?2) Major pathophysiologic defects in type 2 diabetes 3) ADA/EASD and AACE treatment goals 4) Non-pharmacologic and pharmacologic treatment options 5) Diabetes technology/devices 6) Case studies in diabetes
12:05 PM – 12:15 PM / 9:05 AM – 9:15 AM (PT) ~ BREAK
12:15 PM – 1:15 PM (ET) / 9:15 AM – 10:15 AM (PT):
Colon Cancer Update 2020– Dr. Rimma Shaposhnikov
Objective: 1) Increase compliance with colon cancer screening in the general population 2) Review available colon cancer screening tests and the latest guidelines
1:15 PM – 1:20 PM (ET) / 10:15 AM – 10:20 AM (PT) ~ BREAK
1:20 PM – 2:20 PM (ET) / 10:20 AM – 11:20 AM (PT):
Celiac Disease – What’s in a Name?– Dr. Rimma Shaposhnikov
Objective: To raise awareness of which patients should be screened for celiac disease and to provide the tools necessary to differentiate between gluten disorders
Note: Content is subject to change without notice. Please refer to the activity website for the most current information.
Special Promotion: This webinar is part of an ongoing Primary Care Update CME Series. Get all three webinars and 24 hrs of CME for the price of two!
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved